94 related articles for article (PubMed ID: 19606194)
61. Prevalence of cytomegalovirus antibody in nursing personnel.
Lipscomb JA; Linnemann CC; Hurst PF; Myers MG; Stringer W; Moore P; Hammond J
Infect Control; 1984 Nov; 5(11):513-8. PubMed ID: 6094379
[TBL] [Abstract][Full Text] [Related]
62. Cytomegalovirus in Australian blood donors: seroepidemiology and seronegative red blood cell component inventories.
Lancini DV; Faddy HM; Ismay S; Chesneau S; Hogan C; Flower RL
Transfusion; 2016 Jun; 56(6 Pt 2):1616-21. PubMed ID: 26801676
[TBL] [Abstract][Full Text] [Related]
63. Prevalence of cytomegalovirus infection in Italy.
de Mattia D; Stroffolini T; Arista S; Pistoia D; Giammanco A; Maggio M; Chiaramonte M; Moschen ME; Mura I; Rigo G
Epidemiol Infect; 1991 Oct; 107(2):421-7. PubMed ID: 1657625
[TBL] [Abstract][Full Text] [Related]
64. Screening plasma donors for high-titre antibody to cytomegalovirus using a latex agglutination test.
McDonald C; Barbara JA; al-Izzi A; Contreras M
Vox Sang; 1990; 59(2):83-5. PubMed ID: 2173280
[TBL] [Abstract][Full Text] [Related]
65. Association between cytomegalovirus seropositivity and Type 2 diabetes is explained by age and other demographic characteristics: the National Health and Nutrition Examination Survey.
Schmidt L; Nelson HH; Thyagarajan B; Hunter-Schlichting D; Pankow JS; Capistrant B; Prizment AE
Diabet Med; 2018 Dec; 35(12):1722-1726. PubMed ID: 30022533
[TBL] [Abstract][Full Text] [Related]
66. Implications of demographics on future blood supply: a population-based cross-sectional study.
Greinacher A; Fendrich K; Brzenska R; Kiefel V; Hoffmann W
Transfusion; 2011 Apr; 51(4):702-9. PubMed ID: 20849411
[TBL] [Abstract][Full Text] [Related]
67. Stability of cytomegalovirus antibodies in plasma during prolonged storage of blood components.
Pappin A; Grissom M; Mackay W; Huang Y; Yomtovian R
Clin Diagn Lab Immunol; 1995 Jan; 2(1):25-9. PubMed ID: 7719908
[TBL] [Abstract][Full Text] [Related]
68. The residual risk of transfusion-transmitted cytomegalovirus infection associated with leucodepleted blood components.
Seed CR; Wong J; Polizzotto MN; Faddy H; Keller AJ; Pink J
Vox Sang; 2015 Jul; 109(1):11-7. PubMed ID: 25854287
[TBL] [Abstract][Full Text] [Related]
69. Robotic selective sampling and total automation for anti-CMV screening.
McDonald CP; Cook R; Engel A; Robbins S; Rayfield I; Barbara JA
Transfus Med; 1999 Dec; 9(4):301-5. PubMed ID: 10583883
[TBL] [Abstract][Full Text] [Related]
70. Cytomegalovirus infection in cancer patients receiving granulocyte transfusions.
Narvios A; Pena E; Han XY; Lichtiger B
Blood; 2002 Jan; 99(1):390-1. PubMed ID: 11783435
[No Abstract] [Full Text] [Related]
71. Cytomegalovirus infection in blood donors--a prospective study.
Perham TG; Caul EO; Conway PJ; Mott MG
Br J Haematol; 1971 Mar; 20(3):307-20. PubMed ID: 4324060
[No Abstract] [Full Text] [Related]
72. The 'Donor of the Future Project' - first results and further research domains.
Sundermann LM; de Kort WL; Boenigk S
Vox Sang; 2017 Apr; 112(3):191-200. PubMed ID: 28220496
[TBL] [Abstract][Full Text] [Related]
73. The incidence of HIV among blood donors in Kaduna, Nigeria.
Hassan A; Muktar HM; Mamman AI; Ahmed AJ; Isa AH; Babadoko AA
Afr Health Sci; 2007 Dec; 7(4):253. PubMed ID: 21499493
[No Abstract] [Full Text] [Related]
74. Haemoglobin variants among voluntary blood donors in Jos, Nigeria: the implications on blood transfusion.
Damulak OD; Bolorunduro SA; Egesie JO; Yakubu K; Godit P; Smith OA
Niger J Med; 2013; 22(1):64-7. PubMed ID: 23441524
[TBL] [Abstract][Full Text] [Related]
75. Cytomegalovirus in blood from blood donors.
Contreras M; Barbara JA; McDonald C
BMJ; 1989 Oct; 299(6707):1098. PubMed ID: 2556196
[No Abstract] [Full Text] [Related]
76. [Demographic and psychosociological study of volunteer blood donors of the Toulouse region].
MONTALEGRE J; COLOMBIES P; ASTRE C
Toulouse Med; 1962 Mar; 63():317-34. PubMed ID: 14475467
[No Abstract] [Full Text] [Related]
77. [Demographical and psychosociological study of voluntary blood donors in the region of Toulouse].
MONTALEGRE J; COLOMBIES P; ASTRE C
Transfusion (Paris); 1961; 4():201-16. PubMed ID: 14475468
[No Abstract] [Full Text] [Related]
78. [Value of certain blood variables in blood-donors in Zagreb].
TIEFENBACH B; BUZINA R; VOUK V
Lijec Vjesn; 1959; 81():637-45. PubMed ID: 13838331
[No Abstract] [Full Text] [Related]
79. Cytomegalovirus infection among Human Immunodeficiency Virus (HIV) infected individuals on highly active anti-retroviral therapy in North-Central Nigeria.
Udeze A; Odebisi-Omokanye M; Ajileye T
Afr Health Sci; 2018 Dec; 18(4):1057-1065. PubMed ID: 30766572
[TBL] [Abstract][Full Text] [Related]
80. Ongoing burden of disease and mortality from HIV/CMV coinfection in Africa in the antiretroviral therapy era.
Adland E; Klenerman P; Goulder P; Matthews PC
Front Microbiol; 2015; 6():1016. PubMed ID: 26441939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
